Eribaxaban

Drug Profile

Eribaxaban

Alternative Names: PD 0348292; PD 348292

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Antithrombotics; Pyridones; Pyrrolidines; Small molecules
  • Mechanism of Action Factor Xa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Venous thrombosis

Most Recent Events

  • 08 Feb 2010 Discontinued - Phase-II for Venous thrombosis in USA (PO)
  • 07 Nov 2007 Pharmacodynamics data from a preclinical iliac venous stenting study presented at the 80th Scientific Sessions of the American Heart Association (AHA-2007)
  • 22 May 2006 Phase-II clinical trials in Venous thrombosis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top